FS KKR Capital’s Double-Digit Dividend Yield Masks a Deepening Credit and Legal Storm

The Business Development Company (BDC) sector has long been a haven for income hunters, but FS KKR Capital is testing that faith. The stock currently yields 16.4% — more than 600 basis points above rival Ares Capital’s 10.3% payout — yet that headline number comes with a warning. Investors are pursuing $880 million in damages over allegations the company misled them about the health of its portfolio, while a series of dividend cuts has wiped out more than half the quarterly payout in little over a year.

The most recent reduction, from $0.48 to $0.42 per share in the first quarter of 2026, left the annualized distribution at $1.80 — exactly half the level paid in early 2025. The Febuary cut from $0.70 to $0.48 had already triggered a 15% single-day plunge in the stock to $11.29. Shareholders who bought at the 52-week high of $19.38 have seen the value of their equity more than halve, with the stock now trading around €9.45 on Tradegate.

Behind the dividend slide lies a deteriorating balance sheet. FS KKR Capital’s net asset value per share dropped from $21.93 in August 2025 to $20.89 by the end of February 2026, a decline of roughly 5% in the fourth quarter alone. Over the same six-month stretch the overall investment portfolio shrank by $880 million to approximately $13 billion. Non-accruing loans climbed alongside the falling valuations, a pattern that has unsettled even veteran BDC investors.

Should investors sell immediately? Or is it worth buying FS KKR Capital?

The legal headaches compound the picture. Multiple law firms — including Berger Montague, Robbins Geller, and Bernstein Liebhard — have filed securities class-action suits covering purchases between May 8, 2024 and February 25, 2026. The core allegation is that the company systematically overstated the success of its portfolio restructuring and understated the risk embedded in its investments. Investors who want to act as lead plaintiffs must file motions by July 6, 2026.

Despite the turmoil, the stock has crawled off its 52-week low of €8.61, helped in part by a $150 million share repurchase program announced by parent KKR. The recovery has pushed the relative strength index to 74.6, suggesting the recent rally may be overstretched. The stock’s beta of 0.85 indicates it moves less aggressively than the broader market, a thin comfort when the fundamental trends are pointing south.

Analyst sentiment underscores the divergence in the BDC space. The consensus price target for FS KKR Capital stands at $10.58, implying a further 3.7% downside from current levels. By contrast, Ares Capital commands a target of $20.75, representing nearly 11% upside. A detailed comparison across 16 metrics — including payout ratios, volatility, and portfolio quality — gave Ares the edge in 12 categories. The message: the higher yield is compensation for risk, not a bargain.

Meanwhile, KKR & Co. has been active on other fronts. It led an $80 million funding round for Fresha, an AI-powered beauty and wellness platform valued at over $1 billion. It is also reportedly weighing an improved offer for Irish energy distributor DCC, with a binding-bid deadline of June 10. These moves, however do little to address the immediate challenges at FS KKR Capital. The next portfolio disclosures, due by mid-2026, will be critical in determining whether the NAV slide can be arrested — or whether the dividend yield is simply a trap.

Ad

FS KKR Capital Stock: New Analysis - 22 May

Fresh FS KKR Capital information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated FS KKR Capital analysis...

en | US3026352068 | KKR | boerse | 69395083 |